Jun 9, 2021, 5:03 PM IST
The United States Food and Drug Administration has approved Aduhelm for the treatment of Alzheimer's disease, a progressive neurodegenerative disease that destroys the brain's neurons and cells and impairs cognitive abilities and memory.